Literature DB >> 25370748

Spinal cord damage in Machado-Joseph disease.

Camila N Fahl1, Lucas Melo T Branco, Felipe P G Bergo, Anelyssa D'Abreu, Iscia Lopes-Cendes, Marcondes C França.   

Abstract

Machado-Joseph disease (SCA3) is the most frequent spinocerebellar ataxia worldwide and characterized by remarkable phenotypic heterogeneity. MRI-based studies in SCA3 focused in the cerebellum and connections, but little is known about cord damage in the disease and its clinical relevance. To evaluate the spinal cord damage in SCA3 through quantitative analysis of MRI scans. A group of 48 patients with SCA3 and 48 age and gender-matched healthy controls underwent MRI on a 3T scanner. We used T1-weighted 3D images to estimate the cervical spinal cord area (CA) and eccentricity (CE) at three C2/C3 levels based on a semi-automatic image segmentation protocol. The scale for assessment and rating of ataxia (SARA) was employed to quantify disease severity. The two groups-SCA3 and controls-were significantly different regarding CA (49.5 ± 7.3 vs 67.2 ± 6.3 mm(2), p < 0.001) and CE values (0.79 ± 0.06 vs 0.75 ± 0.05, p = 0.005). In addition, CA presented a significant correlation with SARA scores in the patient group (p = 0.010). CE was not associated with SARA scores (p = 0.857). In the multiple variable regression, we found that disease duration was the only variable associated with CA (coefficient = -0.629, p = 0.025). SCA3 is characterized by cervical cord atrophy and antero-posterior flattening. In addition, the spinal cord areas did correlate with disease severity. This suggests that quantitative analyses of the spinal cord MRI might be a useful biomarker in SCA3.

Entities:  

Mesh:

Year:  2015        PMID: 25370748     DOI: 10.1007/s12311-014-0619-7

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  20 in total

1.  Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.

Authors:  Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale
Journal:  Neuron       Date:  2002-01-31       Impact factor: 17.173

2.  Pattern of peripheral nerve involvement in Machado-Joseph disease: neuronopathy or distal axonopathy? A clinical and neurophysiological evaluation.

Authors:  Marcio Luiz Escorcio Bezerra; José Luiz Pedroso; Denise Spinola Pinheiro; Pedro Braga-Neto; Orlando Graziani Povoas Barsottini; Nadia Iandoli de Oliveira Braga; Gilberto Mastrocola Manzano
Journal:  Eur Neurol       Date:  2012-12-07       Impact factor: 1.710

3.  Neocortical atrophy in Machado-Joseph disease: a longitudinal neuroimaging study.

Authors:  Anelyssa D'Abreu; Marcondes C França; Clarissa L Yasuda; Bruno A G Campos; Iscia Lopes-Cendes; Fernando Cendes
Journal:  J Neuroimaging       Date:  2011-06-23       Impact factor: 2.486

4.  CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1.

Authors:  Y Kawaguchi; T Okamoto; M Taniwaki; M Aizawa; M Inoue; S Katayama; H Kawakami; S Nakamura; M Nishimura; I Akiguchi
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

5.  Widespread neuronal damage and cognitive dysfunction in spinocerebellar ataxia type 3.

Authors:  Tátila Martins Lopes; Anelyssa D'Abreu; Marcondes Cavalcante França; Clarissa Lin Yasuda; Luiz Eduardo Betting; Adriana Bastos Samara; Gabriela Castellano; Júlio César Somazz; Marcio Luiz Figueredo Balthazar; Iscia Lopes-Cendes; Fernando Cendes
Journal:  J Neurol       Date:  2013-06-18       Impact factor: 4.849

Review 6.  Caring for Machado-Joseph disease: current understanding and how to help patients.

Authors:  Anelyssa D'Abreu; Marcondes C França; Henry L Paulson; Iscia Lopes-Cendes
Journal:  Parkinsonism Relat Disord       Date:  2009-10-06       Impact factor: 4.891

7.  A multimodal evaluation of microstructural white matter damage in spinocerebellar ataxia type 3.

Authors:  Rachel P Guimarães; Anelyssa D'Abreu; Clarissa L Yasuda; Marcondes C França; Beatriz H B Silva; Fabio A M Cappabianco; Felipe P G Bergo; Iscia T Lopes-Cendes; Fernando Cendes
Journal:  Mov Disord       Date:  2013-04-03       Impact factor: 10.338

Review 8.  New insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado-Joseph disease).

Authors:  Udo Rüb; Ewout R Brunt; Thomas Deller
Journal:  Curr Opin Neurol       Date:  2008-04       Impact factor: 5.710

Review 9.  Polyglutamine neurodegeneration: protein misfolding revisited.

Authors:  Aislinn J Williams; Henry L Paulson
Journal:  Trends Neurosci       Date:  2008-09-06       Impact factor: 13.837

10.  Prospective study of peripheral neuropathy in Machado-Joseph disease.

Authors:  Marcondes C França; Anelyssa D'abreu; Anamarli Nucci; Fernando Cendes; Iscia Lopes-Cendes
Journal:  Muscle Nerve       Date:  2009-12       Impact factor: 3.217

View more
  16 in total

1.  Phonoarticulation in spinocerebellar ataxia type 3.

Authors:  A E Wolf; L Mourão; M C França; A J Machado Júnior; A N Crespo
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-04       Impact factor: 2.503

Review 2.  Dilemma of multiple system atrophy and spinocerebellar ataxias.

Authors:  Ming Li; Qianqian Ma; Xing Zhao; Can Wang; Huijie Wu; Jinyao Li; Wei Yang
Journal:  J Neurol       Date:  2018-04-26       Impact factor: 4.849

3.  MR Imaging in Spinocerebellar Ataxias: A Systematic Review.

Authors:  A Klaes; E Reckziegel; M C Franca; T J R Rezende; L M Vedolin; L B Jardim; J A Saute
Journal:  AJNR Am J Neuroradiol       Date:  2016-05-12       Impact factor: 3.825

4.  Spinal Cord Damage in Spinocerebellar Ataxia Type 1.

Authors:  Carlos Roberto Martins; Alberto Rolim Muro Martinez; Thiago Junqueira Ribeiro de Rezende; Lucas Melo Teixeira Branco; José Luiz Pedroso; Orlando G P Barsottini; Iscia Lopes-Cendes; Marcondes C França
Journal:  Cerebellum       Date:  2017-08       Impact factor: 3.847

5.  Pattern of cerebellar grey matter loss associated with ataxia severity in spinocerebellar ataxias type 3: a multi-voxel pattern analysis.

Authors:  Jianping Hu; Xinyuan Chen; Mengcheng Li; Hao-Ling Xu; Ziqiang Huang; Naping Chen; Yuqing Tu; Qunlin Chen; Shirui Gan; Dairong Cao
Journal:  Brain Imaging Behav       Date:  2021-08-21       Impact factor: 3.978

Review 6.  Rating scales and biomarkers for CAG-repeat spinocerebellar ataxias: Implications for therapy development.

Authors:  Meng-Ling Chen; Chih-Chun Lin; Liana S Rosenthal; Puneet Opal; Sheng-Han Kuo
Journal:  J Neurol Sci       Date:  2021-04-01       Impact factor: 3.181

Review 7.  Spinocerebellar ataxia clinical trials: opportunities and challenges.

Authors:  Sarah M Brooker; Chandrakanth Reddy Edamakanti; Sara M Akasha; Sheng-Han Kuo; Puneet Opal
Journal:  Ann Clin Transl Neurol       Date:  2021-05-21       Impact factor: 4.511

Review 8.  Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view.

Authors:  Giulia Coarelli; Alexis Brice; Alexandra Durr
Journal:  F1000Res       Date:  2018-11-12

9.  Cervical Spinal Cord Degeneration in Spinocerebellar Ataxia Type 7.

Authors:  C R Hernandez-Castillo; R Diaz; T J R Rezende; I Adanyeguh; I H Harding; F Mochel; J Fernandez-Ruiz
Journal:  AJNR Am J Neuroradiol       Date:  2021-07-01       Impact factor: 4.966

10.  CAG repeat length does not associate with the rate of cerebellar degeneration in spinocerebellar ataxia type 3.

Authors:  Shang-Ran Huang; Yu-Te Wu; Chii-Wen Jao; Bing-Wen Soong; Jiing-Feng Lirng; Hsiu-Mei Wu; Po-Shan Wang
Journal:  Neuroimage Clin       Date:  2016-11-10       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.